Informação sobre produto
- Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-2-hydroxy-3-methyl-, (2S)-
- (2S)-N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-2-hydroxy-3-methylbutanamide
- LY 900009
LY-900009 is a small molecule that inhibits the activity of the protease secretase. LY-900009 has been shown to inhibit the growth of breast cancer cells and increase survival rates in animal models. LY-900009 may be an important drug for treating solid tumours, especially those that are resistant to other therapies. LY-900009 was also found to be effective at preventing the regrowth of tumours after treatment with chemotherapy or radiotherapy. This agent has been shown to enhance the sensitivity of cancer cells to chemotherapy, by inhibiting β-catenin protein expression and cell cycle progression. It is also known to inhibit epidermal growth factor receptor (EGFR) signalling, which has been implicated in tumorigenesis.
Propriedades químicas
Consulta técnica sobre: 3D-JIA98468 LY-900009
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
